MARKET-STRUCTURE AND CONDUCT IN THE PHARMACEUTICAL-INDUSTRY

被引:7
作者
CRAIG, AM
MALEK, M
机构
[1] UNIV ST ANDREWS, PHARMACOECON RES CTR, ST ANDREWS, FIFE, SCOTLAND
[2] UNIV DUNDEE, PHARMACOECON RES CTR, DUNDEE, SCOTLAND
关键词
PHARMACEUTICAL INDUSTRY; MARKET STRUCTURE; OLIGOPOLY; MULTINATIONAL; RESEARCH AND DEVELOPMENT;
D O I
10.1016/0163-7258(95)00002-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmaceutical industry offers the world's population alleviation and cure from a variety of medical conditions, while also contributing to the economic performance of many countries. The potential importance of these characteristics have made the industry an area of intense debate, criticism and praise. This review aims to clarify some of the arguments surrounding the industry on both sides of the fence, and by doing so, to provide a balanced introduction on which opinions may be made.
引用
收藏
页码:301 / 337
页数:37
相关论文
共 95 条
[1]  
[Anonymous], 1993, ECONOMIST 0327
[2]   SCIENTIFIC VERSUS COMMERCIAL SOURCES OF INFLUENCE ON THE PRESCRIBING BEHAVIOR OF PHYSICIANS [J].
AVORN, J ;
CHEN, M ;
HARTLEY, R .
AMERICAN JOURNAL OF MEDICINE, 1982, 73 (01) :4-8
[3]  
AYANIAN R, 1975, DRUG DEVMARKETING 2, P81
[4]   RESEARCH AND DEVELOPMENT COSTS AND RETURNS - US PHARMACEUTICAL INDUSTRY [J].
BAILY, MN .
JOURNAL OF POLITICAL ECONOMY, 1972, 80 (01) :70-85
[5]  
Bain JS, 1956, BARRIERS NEW COMPETI, DOI 10.4159/harvard.9780674188037
[6]  
BALLANCE R, 1992, WORLDS PHARM IND INT
[7]  
BAUMOL WJ, 1982, AM EC REV MAR, P1
[8]  
BLAIR P, 1993, FINANCIAL TIMES 0126
[9]   RECENT ISSUES AND CONCERNS ABOUT PHARMACEUTICAL-INDUSTRY PROMOTIONAL EFFORTS [J].
BLEIDT, B .
JOURNAL OF DRUG ISSUES, 1992, 22 (02) :407-415
[10]  
BROWNLEE OH, 1979, ISSUES PHARM EC, P215